Setting priorities for new vaccination programs by using public health officers and immunization managers opinions

Vaccine

Volumn 26, Issue 33, 2008, Pages 4204-4209

  Gilca, Vladimir ^a   Sauvageau, Chantal ^a   McNeil, Shelly ^b   Gemmill, Ian M ^c   Dionne, Marc ^a   Dobson, Simon ^d   Ouakki, Manale ^a   Lavoie, France ^a   Duval, Bernard ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Kingston   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Health professionals; New vaccines; Opinions

Indexed keywords

ACYW 135; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ARTICLE; CLINICAL DECISION MAKING; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; INFECTION PREVENTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; VACCINATION;

CANADA; HEALTH PERSONNEL; HEALTH PRIORITIES; HUMANS; IMMUNIZATION PROGRAMS; PUBLIC HEALTH ADMINISTRATION; QUESTIONNAIRES; VACCINATION; VACCINES;

EID: 47349122180     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.061     Document Type: Article

References (24)

1. van der Zeijst B.A., Dijkman M.I., Luytjes W., et al. On the design of national vaccination programmes. Vaccine 25 (2007) 3143-3145
2. Plotkin S.A. Vaccines: past, present and future. Nat Med 11 (2005) S5-11
3. Jacobson R.M., Targonski P.V., and Poland G.A. Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases. Vaccine 25 (2007) 3165-3169
4. Public Health Agency of Canada. National Immunisation Strategy-Final report 2003. (http://www.phac-aspc.gc.ca/publicat/nat_immunization_03/b2.html).
5. Lee G.M., Santoli J.M., Hannan C., et al. Gaps in vaccine financing for underinsured children in the United States. JAMA 298 (2007) 638-643
6. Kimman T.J., Boot H.A.M., Berbers G., et al. Developing a vaccination evaluation model to support evidence-based decision-making on national immunization programs. Vaccine 24 (2006) 4769-4778
7. Batson A. Sustainable introduction of affordable new vaccines: the targeting strategy. Vaccine 16 (1998) S93-S98
8. Centers for Disease Control Prevention. Framework for program evaluation in public health. MMWR (1999) 48
9. Issel M.L. Health program planning and evaluation: a practical, systematic approach for community health (2004), Jones & Barlette, Chicago
10. Vilnius D., and Dandoy S. A priority rating system for public health programs. Public Health Rep 105 (1990) 463-470
11. Erickson L.J., De Wals P., and Farand L. An analytical framework for immunization programs in Canada. Vaccine 23 (2005) 2470-2476
12. Mitton C., and Donaldson C. Setting priorities in Canadian regional health authorities: a survey of key decision makers. Health Policy 60 (2002) 39-58
13. Duval B., Gilca V., McNeil S., et al. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 25 (2007) 7841-7847
14. Dillman D.A. Mail and internet surveys-the tailored design method (2000), John Wiley & Sons, New York
15. Pineault R, Daveluy C. La planification de la santé-concept-méthodes-stratégies. Ottawa, 1995.
16. Dionne M., Boulianne N., Duval B., et al. Manque de conviction face à la vaccination chez certains vaccinateurs québécois. Rev can santé publique 92 (2001) 100-104
17. Jelleyman T., and Ure A. Attitudes to immunisation: a survey of health professionals in the Rotorua District. N Z Med J 117 (2004) U769
18. Simpson E., Wittet S., Bonilla J., et al. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries. BMC Public Health 7 (2007) 1-11
19. Douglas Jr. R.G. The Jeremiah Metzger Lecture. Vaccine prophylaxis today: its science, application and politics. Trans Am Clin Climatol Assoc 109 (1998) 185-196 discussion 96-8.
20. Stevenson C.G., McArthur M.A., Naus M., et al. Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?. Can Med Assoc J 164 (2001) 1413-1419
21. Glezen W.P., and Simonsen L. Commentary: benefits of influenza vaccine in US elderly-new studies raise questions. Int J Epidemiol 35 (2006) 352-353
22. Murphy T.V., Gargiullo P.M., Massoudi M.S., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344 (2001) 564-572
23. Mahoney R.T., Krattiger A., Clemens J.D., et al. The introduction of new vaccines into developing countries. IV: global access strategies. Vaccine 25 (2007) 4003-4011
24. DeRoeck D., Clemens J.D., Nyamete A., et al. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 23 (2005) 2762-2774